Literature DB >> 18950393

Methicillin-resistant Staphylococcus aureus colonization in children with atopic dermatitis.

Liza Suh1, Susan Coffin, Kateri Heydon Leckerman, Joel M Gelfand, Paul J Honig, Albert C Yan.   

Abstract

Children with atopic dermatitis are more frequently colonized with Staphylococcus aureus than children without atopic dermatitis. However, little epidemiological data exist regarding the prevalence of methicillin-resistant S. aureus among children with atopic dermatitis. Recent studies have revealed an increasing prevalence of community-associated methicillin-resistant S. aureus among patients presenting to hospitals with serious bacterial infections, particularly those with cutaneous and soft tissue infections. As many atopic dermatitis patients are treated empirically with antibiotics for secondary skin infections, an understanding of the epidemiology of bacterial colonization and superinfection is essential for directing proper treatment in the atopic patient population. This study investigates the prevalence of risk factors for community-associated, methicillin-resistant S. aureus colonization among pediatric atopic dermatitis patients encountered at an academic pediatric dermatology clinic. An observational cross-sectional study was conducted at the Children's Hospital of Philadelphia in which 54 patients previously diagnosed with atopic dermatitis were enrolled. A detailed patient questionnaire, a complete cutaneous examination, and an evaluation of eczema severity according to the Eczema Area and Severity Index were completed at the time of enrollment. Bacterial cultures from the skin and nares were obtained to determine the frequency of colonization with either methicillin-sensitive S. aureus or methicillin-resistant S. aureus. Although most atopic dermatitis patients studied were colonized with S. aureus (43/54 [80%]), methicillin-resistant S. aureus was isolated from only seven atopic dermatitis patients (7/43 [16%]). Patients colonized with S. aureus were more likely to be male, to have been previously hospitalized, to have used a topical calcineurin inhibitor in combination with a topical steroid, and less likely to have used topical antibiotics. Bivariable analysis, however, revealed that only previous hospitalization was independently associated with an increased risk of methicillin-resistant S. aureus colonization. We observed that 80% of atopic dermatitis patients were colonized with S. aureus, and that of these patients, 16% of colonized patients were colonized with a methicillin-resistant strain. Methicillin-resistant S. aureus colonization was found to be significantly associated with previous hospitalization. Evidence also indicates that topical calcineurin inhibitors used in conjunction with topical steroids is associated with increased S. aureus colonization, while topical antibiotic use appears to decrease S. aureus colonization.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18950393     DOI: 10.1111/j.1525-1470.2008.00768.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  19 in total

Review 1.  Colonization, pathogenicity, host susceptibility, and therapeutics for Staphylococcus aureus: what is the clinical relevance?

Authors:  Steven Y C Tong; Luke F Chen; Vance G Fowler
Journal:  Semin Immunopathol       Date:  2011-12-11       Impact factor: 9.623

2.  High prevalence of mupirocin resistance in Staphylococcus aureus isolates from a pediatric population.

Authors:  Nina K Antonov; Maria C Garzon; Kimberly D Morel; Susan Whittier; Paul J Planet; Christine T Lauren
Journal:  Antimicrob Agents Chemother       Date:  2015-03-30       Impact factor: 5.191

Review 3.  Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic.

Authors:  Michael Z David; Robert S Daum
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

4.  Treatment outcomes of secondarily impetiginized pediatric atopic dermatitis lesions and the role of oral antibiotics.

Authors:  Jeffrey B Travers; Amal Kozman; Yongxue Yao; Wenyu Ming; Weiguo Yao; Mathew J Turner; Mark H Kaplan; Nico Mousdicas; Anita N Haggstrom; Chandan Saha
Journal:  Pediatr Dermatol       Date:  2011-12-09       Impact factor: 1.588

5.  Staphylococcus aureus and Staphylococcus epidermidis strain diversity underlying pediatric atopic dermatitis.

Authors:  Allyson L Byrd; Clay Deming; Sara K B Cassidy; Oliver J Harrison; Weng-Ian Ng; Sean Conlan; Yasmine Belkaid; Julia A Segre; Heidi H Kong
Journal:  Sci Transl Med       Date:  2017-07-05       Impact factor: 17.956

6.  Comparative proteomic profiling of patients with atopic dermatitis based on history of eczema herpeticum infection and Staphylococcus aureus colonization.

Authors:  Carolyn J Broccardo; Spencer Mahaffey; John Schwarz; Lisa Wruck; Gloria David; Patrick M Schlievert; Nichole A Reisdorph; Donald Y M Leung
Journal:  J Allergy Clin Immunol       Date:  2011-01       Impact factor: 10.793

7.  A proposal: Atopic Dermatitis Organizer (ADO) guideline for children.

Authors:  Sang-Il Lee; Jihyun Kim; Youngshin Han; Kangmo Ahn
Journal:  Asia Pac Allergy       Date:  2011-07-28

8.  High prevalence of methicillin resistance and PVL genes among Staphylococcus aureus isolates from the nares and skin lesions of pediatric patients with atopic dermatitis.

Authors:  F S Cavalcante; E D Abad; Y C Lyra; S B Saintive; M Ribeiro; D C Ferreira; K R N dos Santos
Journal:  Braz J Med Biol Res       Date:  2015-05-08       Impact factor: 2.590

9.  Methicillin-Resistant Staphylococcus aureus Colonization Is Associated with Decreased Skin Commensal Bacteria in Atopic Dermatitis.

Authors:  Baochen Shi; Donald Y M Leung; Patricia A Taylor; Huiying Li
Journal:  J Invest Dermatol       Date:  2018-02-08       Impact factor: 8.551

10.  Novel sodium hypochlorite cleanser shows clinical response and excellent acceptability in the treatment of atopic dermatitis.

Authors:  Caitriona Ryan; Richard E Shaw; Clay J Cockerell; Shari Hand; Fred E Ghali
Journal:  Pediatr Dermatol       Date:  2013 May-Jun       Impact factor: 1.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.